EVERYTHING XIAOMI
Get listed
Side by side

EPPI-Reviewer vs RevMan

RevMan

7.8#1 in systematic review softwareFrom £80 a year
Free planWebLinuxmacOSWindows
Visit

What both publish

FactEPPI-ReviewerRevMan
HeadquartersLondon, UKLondon, United Kingdom
MakerEPPI-Reviewer is developed and maintained by the EPPI Centre, which the maker describes as part of UCL’s Social Science Research Unit and UCL Social Research Institute.RevMan and Cochrane Interactive Learning are distributed and sold by The Cochrane Collaboration, a registered charity and company limited by guarantee in England and Wales.
PurposeEPPI-Reviewer is web-based software for managing and analysing literature-review data, including systematic reviews and meta-analyses.RevMan is Cochrane’s software for producing transparent systematic reviews, guiding authors from structured data entry and analysis through result visualization.

EPPI-Reviewer plans

  • User fee£10 a month
  • Shareable review fee£35 a month
  • Direct support — hourly£80, paid once
  • Direct support — full day£500, paid once

RevMan plans

  • Practice reviewFree
  • Cochrane author accessFree
  • Individual student annual subscription£80 a year
  • Student£80 a year
  • Academic£100 a year
  • Individual academic annual subscription£100 a year

Pick EPPI-Reviewer if…

EPPI-Reviewer suits researchers managing systematic reviews, meta-analyses or other literature reviews who need screening automation and qualitative or quantitative analysis. It is web-based and includes a one-month trial for account holders.

Pick RevMan if…

RevMan suits authors preparing systematic reviews across its listed review types, including people working collaboratively on analysis and writing. The free practice option may suit someone who can work within its deletion, export, and single-user limits.

Charts they share